Corbus Pharmaceuticals Holdings, Inc.
CRBP
$10.03
$0.141.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -76.67% | -146.09% | -18.80% | -37.10% | -13.81% |
| Total Depreciation and Amortization | -64.67% | -46.71% | -9.46% | -0.65% | -5.12% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -62.75% | -42.33% |
| Total Other Non-Cash Items | 212.68% | 1,792.31% | 46.14% | 138.17% | -61.93% |
| Change in Net Operating Assets | -75.00% | 32.71% | -357.84% | -210.76% | 425.99% |
| Cash from Operations | -85.61% | -106.11% | -82.12% | -94.29% | -14.64% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 207.93% | 118.45% | -15.96% | -241.00% | -286.65% |
| Cash from Investing | 207.93% | 118.45% | -15.96% | -241.00% | -286.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -1,370.58% | -1,391.77% |
| Issuance of Common Stock | -- | -- | -- | -- | 21,813.48% |
| Repurchase of Common Stock | -- | -- | 82.43% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 99.32% | 3,150.43% | 194,150.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.06% | 349.08% | -189.90% | -247.00% | 835.57% |